ZHANG Wei-Ling,ZHANG Yi,HUANG Dong-Sheng et al. General therapy of pediatric malignant germinoma: experience of 7 cases[J]. CJCP, 2011, 13(2): 163-164.
［2］Billmire DF, Grosfeld JL. Teratomas in childhood: analysis of 142 cases［J］. J Pediatr Surg,1986,21(6):548-551.
［3］Cangir A, Smith J, van Eys J. Improved prognosis in children with ovarian cancers following modified VAC(vincristine sulfate, dactinomycin, and cyclophosphamide)chemotherapy［J］. Cancer,1978,42(3):1234-1238.
［4］Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin,and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors:a pediatric intergroup study-Pediatric Oncology Group 9049 and Children's Cancer Group 8882［J］. J Clin Oncol, 2004, 22(13):2691-2700.
［7］Muramaki M, Hara I, Miyate H, Yamada Y, Kawabata G, Kamidono S. Advances in the management of non-seminomatous germ cell tumors durin the cisplatin era: A single-institution experience［J］. Int J Urol, 2004,11(9):768-773.
［8］Hinton S, Catalano PJ, Einborn LH, Nichols CR, David Crawford E, Vogelzang N, et al. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of dissenminated germ cell tumors: final analysis of an intergroup trial［J］. Cancer, 2003,97(8):1869-1875.
